Treatment of Type II Diabetes

  • Uncategorized

TREATMENT OF TYPE II DIABETES 4

Treatmentof Type II Diabetes NameInstitutionTreatmentof Type II Diabetes Diabeticpatients who do not take medication regularly as prescribed requirealternative treatment plan. Possibly, Bob needs three to six weekstreatment residential program so as to manage type II diabetes. Thebenefits of residential treatment for type II diabetes is that he canreduce his weight by 15 kg averagely (Inzucchi et al., 2015).Consequently, the weight loss causes changes in the body. First,within seven days into treatment, liver fat is likely to reduce by30%. Secondly, the level of liver insulin sensitivity returns tooptimal. Third, the level of insulin secretion from pancreas getsregular. Themost appropriate drugs that I will recommend for Bob isalpha-glucosidase inhibitors. These include acarbose (Precose) 25mgthree times in a day for 4-6 weeks, and miglitol (Glyset) 25mg threetimes daily for the entire period of treatment. The body reacts tothese drugs by increasing the metabolic rate on some starchy foodsand raw sugar consumed in substance like tea (Kalra, 2014).Consequently, both acarbose and miglitol lead to lower blood sugarlevel. Since Bob AIC stands at 9.5. There is a lot of sugar in hisblood because of two reasons. One, his body does not make enoughinsulin to maintain his blood sugar at the right level second, thebody produces insulin but cannot utilize it properly. Acarboseworks by inactivating enzymes which convert food into sugar hencelowering the blood glucose. However, in rare cases, the body mayreact to acarbose resulting in stomachache, diarrhea, and skinrashes. Likewise, miglitol also facilitates hypoglycemia, though itshould be administered together with other drugs, particularlyacarbose (Kim, Rioux &amp Turgeon, 2014). Nonetheless, its sideeffects on the body include soft stool and abdominal pain. Insummary, treatment of a diabetic patient who is overweight and failsin taking drugs regularly must be done in a residential healthfacility. The focus is reducing the patient weight and boosting thelevel of insulin secreted. The two drugs acarbose and miglitol workas enzyme inhibitors, hence prevent the conversion of food intosugar. However, both acarbase and miglitol have some side effects onthe body.

References

Inzucchi,S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E.,Nauck, M., … &amp

Matthews,D. R. (2015). “Management of hyperglycemia in type 2 diabetes,2015: a

patient-centeredapproach: update to a position statement of the American Diabetes

Associationand the European Association for the Study of Diabetes.”&nbspDiabetes

care,&nbsp38(1),140-149.

Kalra,S. (2014). “Alpha glucosidase inhibitors.”&nbspJPMA.The Journal of the Pakistan Medical

Association,&nbsp64(4),474-476.

Kim,K. T., Rioux, L. E., &amp Turgeon, S. L. (2014). “Alpha-amylaseand alpha-glucosidase

inhibitionis differentially modulated by fucoidan obtained from Fucusvesiculosus and

Ascophyllumnodosum.”&nbspPhytochemistry,&nbsp98,27-33.